New York-Presbyterian Hospital New York Study Aims to Assess Utility of Clinical Whole-Genome Sequencing Across Diseases Premium Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients. Weill Cornell Integrates Cancer Exome Test Into EHRs With Eye Toward Next Version Premium After three years of work, the EXaCT-1 exome cancer test has become part of clinical cancer care at NewYork-Presbyterian, but developers have higher ambitions. Biotia Aims to Cut Hospital-Acquired Infections by Monitoring Microbiome of Hospital Environment Premium The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. Columbia U, Life Raft Use Pathway Approach to Find New Therapies for Resistant GI Tumors Premium The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments. Jul 20, 2016 Weill Cornell Medicine to Expand Tumor Exome Test to Thousands of Advanced Cancer Patients Premium Jul 15, 2016 Columbia, New York-Presbyterian Land $58.4M NIH Grant for Personalized Medicine Jan 31, 2013 Weill Cornell, New York-Presbyterian Launch Clinical Genomics Institute May 5, 2010 Researchers Identify Gene Variants That Protect Against Colorectal Cancer with Statin Use Premium Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.